| 1. | The inhibitory effect of tlsfjm on rat cardiac allograft rejection
抑制大鼠心脏移植排斥反应的作用 |
| 2. | Conclusion : mast cells may be involved in the chronic rejection of kidney transplantation and its mechanism remains to be studied
结论：肥大细胞可能参与了肾移植排斥反应，其作用机理尚需进一步研究。 |
| 3. | Prevention and treatment of host rejection a pre - requisite for successful transplantation of donor tissue and stein cells
摘要影响异体角膜缘角膜缘干细胞移植术成败的关键是术后移植排斥反应的防治。 |
| 4. | Dendritic cel1s ( dcs ) are highly potent anigenpresenting cells of bone marrow origin that can stbolate both primary and secondary t - and b - cell responses
Dc是唯一能够激活初始型t细胞的apc ，具有激活移植排斥反应的作用。 |
| 5. | Backgroud : the activation of antigen - specific t cells plays a vital role in the initiation and development of some immune - related diseases , such as transplant rejection and allergic diseases
背景：抗原特异性t细胞的活化在一些免疫相关疾病(如移植排斥反应、变应性疾病)的发生、发展中起着主导性的作用。 |
| 6. | This study summarized mechanisms , clinical findings , early diagnosis of host tissue rejection against keratolimbal allograft / corneal limbal stem cells and the possible prevention and treatment measures
在参阅有关文献后，本文对术后移植排斥反应的机制、表现及早期诊断和处理方法等诸多方面进行了较为全面的综述。 |
| 7. | Recombinated human ctla4ig fusion protein had been used experimentally and clinically in prevention and treatment of transplant rejection , autoimmune diseases and allergic diseases , and positive curiative results were obtained
重组人ctla4ig融合蛋白已被运用于防治移植排斥反应、自身免疫性疾病和变应性疾病等的实验和临床研究，并取得了肯定的效果。 |
| 8. | Hence , yeast gs115 was used to express the target protein in this study . objection : to obtain the biological activated recombianated protein of huaman ctla4 extracellular domain ( ctla4e ) , and to explore its effects on allergic diseases and transplant rejection
目的：获取具有生物学活性的重组人ctla4胞外区蛋白（ ctla4e ） ，探讨其在变应性疾病和器官移植排斥反应防治中的作用和机理。 |
| 9. | Although the development of relatively non - toxic immunosuppressive or tolerance - inducing regimens will be required to justify clinical trials using pig organs , recent advances in our understanding of the biology of xenograft rejection and zoonotic infections , and the generation of alpha1 , 3 - galactosyltransferase - deficient pigs have moved this approach closer to clinical application
尽管用猪的器官进行临床试验尚有赖于相对无毒的免疫抑制剂或致耐方法的发展，但是我们在异种移植排斥反应及猪源人畜共患病等方面生物学知识的进步，以及1 ， 3半乳糖转移酶缺陷猪的产生，已经使异种移植离临床应用更近了一步。 |
